IR Iran
Commentry
Immune Checkpoints of CD8+ T Cells in Acute Myeloid Leukemia
Author(s): Yang J, Liu G, Zhou M, Cheng J, Chen Q and Shen EYang J, Liu G, Zhou M, Cheng J, Chen Q and Shen E
Acute myeloid leukemia (AML) is one of the most common types of hematopoietic malignancy in the adults. Induction chemotherapy followed by post-remission is the general treatment for AML patients with high relapse rate and poor prognosis, which is often related to the CD8+ T cell immune status of the AML patients. Herein, we will make a mini review of phenotype-immune checkpoints expression and function of CD8+ T cells in AML based on our data and other groups, and this might indicate the application of immune checkpoints blockade alone or in combination in AML treatment.
.. Read More»
DOI:
10.4172/1747-0862.1000321
Molecular and Genetic Medicine received 3919 citations as per Google Scholar report